Sep 21, 2026 11 0
Uploaded by Ophelia
Favorite
Share
More Options
8
A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC) - Clinical Trial Protocol_Page 1

Open in WPS to view all 8 pages